These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4470916)

  • 1. The genetics of the Alport syndrome.
    Tishler PV; Rosner B
    Birth Defects Orig Artic Ser; 1974; 10(4):93-9. PubMed ID: 4470916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
    Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
    Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
    Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
    Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J
    Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male-to-male transmission of X-linked Alport syndrome in a boy with a 47,XXY karyotype.
    Ars E; Tazón-Vega B; Ruiz P; Nogués C; Arnedo N; Rajmil O; Torra R
    Eur J Hum Genet; 2005 Sep; 13(9):1040-6. PubMed ID: 15957001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alport syndrome in the light of current molecular genetics].
    Pirson Y
    Bull Mem Acad R Med Belg; 1996; 151(10-11):447-52; discussion 452-3. PubMed ID: 9491622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant Alport's syndrome: study of a large Tunisian family.
    Kharrat M; Makni S; Makni K; Kammoun K; Charfeddine K; Azaeiz H; Jarraya F; Ben Hmida M; Gubler MC; Ayadi H; Hachicha J
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):320-5. PubMed ID: 16970251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
    Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
    Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation in patients with Alport syndrome of knowledge of the disease and attitudes toward prenatal diagnosis.
    Levy M; Pirson Y; Simon P; Boudailliez B; Nivet H; Rancé N; Moynot A; Broyer M; Grünfeld JP
    Clin Nephrol; 1994 Oct; 42(4):211-20. PubMed ID: 7834912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
    Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation in patients with alport syndrome.
    Mojahedi MJ; Hekmat R; Ahmadnia H
    Urol J; 2007; 4(4):234-7. PubMed ID: 18270949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure.
    Colville D; Wang YY; Tan R; Savige J
    Br J Ophthalmol; 2009 Mar; 93(3):383-6. PubMed ID: 19019929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.